2-cyclohexyl-N-[5-[3-(4-piperidin-1-yl-1H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide

C31H34N8O — CID 136936853

IUPAC2-cyclohexyl-N-[5-[3-(4-piperidin-1-yl-1H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide
SMILESO=C(CC1CCCCC1)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(N6CCCCC6)nccc5[nH]4)c3c2)c1
InChIInChI=1S/C31H34N8O/c40-27(15-20-7-3-1-4-8-20)34-23-16-22(18-32-19-23)21-9-10-25-24(17-21)28(38-37-25)30-35-26-11-12-33-31(29(26)36-30)39-13-5-2-6-14-39/h9-12,16-20H,1-8,13-15H2,(H,34,40)(H,35,36)(H,37,38)
InChIKeyZNLZLIYQEPJLOA-UHFFFAOYSA-N
MW534.67 g/mol
LogP6.46
Rot. Bonds6

About 2-cyclohexyl-N-[5-[3-(4-piperidin-1-yl-1H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide

2-cyclohexyl-N-[5-[3-(4-piperidin-1-yl-1H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide (PubChem CID 136936853) has the molecular formula C31H34N8O and a molecular weight of 534.67 g/mol. Its IUPAC name is 2-cyclohexyl-N-[5-[3-(4-piperidin-1-yl-1H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide.

Molecular Properties

Compound Name2-cyclohexyl-N-[5-[3-(4-piperidin-1-yl-1H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide
PubChem CID136936853
Molecular FormulaC31H34N8O
Molecular Weight534.67 g/mol
Exact Mass534.29
IUPAC Name2-cyclohexyl-N-[5-[3-(4-piperidin-1-yl-1H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide
SMILESO=C(CC1CCCCC1)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(N6CCCCC6)nccc5[nH]4)c3c2)c1
InChIInChI=1S/C31H34N8O/c40-27(15-20-7-3-1-4-8-20)34-23-16-22(18-32-19-23)21-9-10-25-24(17-21)28(38-37-25)30-35-26-11-12-33-31(29(26)36-30)39-13-5-2-6-14-39/h9-12,16-20H,1-8,13-15H2,(H,34,40)(H,35,36)(H,37,38)
InChIKeyZNLZLIYQEPJLOA-UHFFFAOYSA-N
XLogP6.46
TPSA115.48 Ų
H-Bond Donors3
H-Bond Acceptors6
Rotatable Bonds6
Heavy Atoms40
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500534.67
LogP ≤ 56.46
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 106

Analyze 2-cyclohexyl-N-[5-[3-(4-piperidin-1-yl-1H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-cyclohexyl-N-[5-[3-(4-piperidin-1-yl-1H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide?
The IUPAC name of 2-cyclohexyl-N-[5-[3-(4-piperidin-1-yl-1H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide (CID 136936853) is 2-cyclohexyl-N-[5-[3-(4-piperidin-1-yl-1H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide.
What is the SMILES notation for 2-cyclohexyl-N-[5-[3-(4-piperidin-1-yl-1H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide?
The canonical SMILES for 2-cyclohexyl-N-[5-[3-(4-piperidin-1-yl-1H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide is O=C(CC1CCCCC1)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(N6CCCCC6)nccc5[nH]4)c3c2)c1.
What is the InChIKey of 2-cyclohexyl-N-[5-[3-(4-piperidin-1-yl-1H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide?
The InChIKey is ZNLZLIYQEPJLOA-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H34N8O/c40-27(15-20-7-3-1-4-8-20)34-23-16-22(18-32-19-23)21-9-10-25-24(17-21)28(38-37-25)30-35-26-11-12-33-31(29(26)36-30)39-13-5-2-6-14-39/h9-12,16-20H,1-8,13-15H2,(H,34,40)(H,35,36)(H,37,38).
What are the key properties of 2-cyclohexyl-N-[5-[3-(4-piperidin-1-yl-1H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide?
2-cyclohexyl-N-[5-[3-(4-piperidin-1-yl-1H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide has a molecular weight of 534.67 g/mol, XLogP of 6.46, 6 rotatable bonds, 3 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 2-cyclohexyl-N-[5-[3-(4-piperidin-1-yl-1H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide is sourced from PubChem (CID 136936853), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).